Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparing Automated Lyumjev® Delivery with Carbohydrate Counting, Qualitative Meal-Size Estimation, and Fully Closed-Loop in Type 1 Diabetes: A Pilot, Randomized, Crossover Trial.

Diabetes technology & therapeutics·2026
Same author

Design and Evaluation of a Novel Clinical Decision Support Algorithm for Weekly Insulin Efsitora Alfa.

Journal of diabetes science and technology·2026
Same author

A three-factor nomogram predicts the use of invasive mechanical ventilation within 72 h in preterm infants.

Frontiers in medicine·2026
Same author

Membrane protein-targeted and dual-miRNAs-activated DNA quadrilateral sensor for accurate tumor cell identification.

Talanta·2026
Same author

Electrostatic complementarity and interlayer coupling modulation in halogen-modified covalent organic frameworks for enhanced photocatalytic oxygen reduction.

Journal of colloid and interface science·2026
Same author

AI-Based Virtual Standardized Patients Improve Oral Mucosal Disease Training in Fourth-Year Dental Students.

Journal of dental education·2026

Related Experiment Video

Updated: May 20, 2026

Electrochemiluminescence Assays for Human Islet Autoantibodies
09:15

Electrochemiluminescence Assays for Human Islet Autoantibodies

Published on: March 23, 2018

Predicting subcutaneous glucose concentration using a latent-variable-based statistical method for type 1 diabetes

Chunhui Zhao1, Eyal Dassau, Lois Jovanovič

  • 1Department of Chemical Engineering, University of California, Santa Barbara, Santa Barbara, California 93106-5080, USA.

Journal of Diabetes Science and Technology
|July 10, 2012
PubMed
Summary

A new latent variable (LV)-based statistical method improves glucose prediction accuracy for type 1 diabetes mellitus (T1DM) management. This approach offers better forecasting than standard models, aiding proactive glycemic control.

More Related Videos

Simple Continuous Glucose Monitoring in Freely Moving Mice
03:25

Simple Continuous Glucose Monitoring in Freely Moving Mice

Published on: February 24, 2023

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets
10:09

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets

Published on: May 11, 2015

Related Experiment Videos

Last Updated: May 20, 2026

Electrochemiluminescence Assays for Human Islet Autoantibodies
09:15

Electrochemiluminescence Assays for Human Islet Autoantibodies

Published on: March 23, 2018

Simple Continuous Glucose Monitoring in Freely Moving Mice
03:25

Simple Continuous Glucose Monitoring in Freely Moving Mice

Published on: February 24, 2023

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets
10:09

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets

Published on: May 11, 2015

Area of Science:

  • Biomedical Engineering
  • Computational Biology
  • Diabetes Technology

Background:

  • Accurate glucose prediction is crucial for managing type 1 diabetes mellitus (T1DM).
  • Leveraging frequent glucose measurements, insulin rates, and carbohydrate estimates can enhance understanding of glucose dynamics.
  • Proactive management requires reliable forecasting of future glucose concentrations.

Purpose of the Study:

  • To evaluate a latent variable (LV)-based statistical method for modeling glucose dynamics.
  • To assess the feasibility of this LV-based approach for forecasting glucose concentrations in T1DM.
  • To compare the prediction accuracy of the LV-based method against standard modeling techniques.

Main Methods:

  • Developed LV-based statistical models for glucose dynamics.
  • Evaluated models using retrospective clinical data from T1DM patients.
  • Validated models with in silico simulations using the FDA-accepted UVA/U Padova metabolic simulator.
  • Compared LV-based method performance against autoregressive (AR) and autoregressive with exogenous input (ARX) models.

Main Results:

  • The LV-based method generally demonstrated superior prediction accuracy compared to conventional AR and ARX models.
  • For prediction horizons of 30 minutes or longer, the LV-based model with exogenous inputs achieved the best performance.
  • Statistical analysis (paired t-test, α = 0.05) confirmed the improved prediction accuracy.

Conclusions:

  • The LV-based method yields glucose prediction models with accuracy comparable to or better than standard AR/ARX models.
  • This novel approach exhibits reduced sensitivity to changing conditions and key design parameters.
  • The LV-based method provides a robust tool for enhancing glucose forecasting in T1DM management.